Stockscreener 앱 받기
1.97
1.03%
0.02
시간 외 거래:
1.94
-0.03
-1.52%
전일 마감가:
$1.95
열려 있는:
$1.94
하루 거래량:
225.56K
Relative Volume:
0.93
시가총액:
$96.49M
수익:
-
순이익/손실:
$-56.85M
주가수익비율:
-1.2636
EPS:
-1.559
순현금흐름:
-
1주 성능:
+3.68%
1개월 성능:
+24.68%
6개월 성능:
-9.63%
1년 성능:
-70.94%
1일 변동 폭
$1.91
$2.00
1주일 범위
$1.79
$2.0374
52주 변동 폭
$0.873
$7.05
Fractyl Health Inc Stock (GUTS) Company Profile
명칭
Fractyl Health Inc
전화
781-902-8800
주소
3 VAN DE GRAAFF DRIVE, BURLINGTON
GUTS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GUTS
Fractyl Health Inc
|
1.97 | 93.06M | 0 | -56.85M | 0 | -1.559 |
|
ONC
Beone Medicines Ltd Adr
|
258.27 | 26.01B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
445.85 | 114.30B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.3499 | 41.83M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
83.98 | 6.29B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
484.93 | 63.90B | 14.09B | 4.50B | 2.96B | 39.28 |
Fractyl Health Inc Stock (GUTS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-02-28 | 개시 | Evercore ISI | Outperform |
| 2024-02-27 | 개시 | BofA Securities | Buy |
| 2024-02-27 | 개시 | Morgan Stanley | Overweight |
Fractyl Health Inc 주식(GUTS)의 최신 뉴스
Fractyl Health and Bariendo Sign Letter of Intent to Prepare for Potential Offering of Revita Across its Bariatric and Metabolic Endoscopy Centers Nationwide - marketscreener.com
Fractyl Health and Bariendo Sign Letter of Intent to - GlobeNewswire
Northern Trust Corp Sells 9,467 Shares of Fractyl Health, Inc. (NASDAQ:GUTS) - Defense World
Fractyl Health, Inc. (NASDAQ:GUTS) Shares Sold by Citadel Advisors LLC - Defense World
Transcript : Fractyl Health, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-14-2025 05 - marketscreener.com
Fractyl Health submits first module of its CTA in Europe for RJVA-001 - TipRanks
Fractyl Health advances gene therapy for diabetes treatment By Investing.com - Investing.com South Africa
Fractyl Health advances gene therapy for diabetes treatment - Investing.com Australia
Fractyl Health Submits Clinical Trial Application in Europe - TipRanks
Fractyl Health Submits First Module of EU Trial Application for Gene Therapy RJVA-001 - marketscreener.com
Fractyl Health Unveils Promising Gene Therapy Data - TipRanks
Fractyl Health Advances Rejuva® Gene Therapy Platform with Submission of First Clinical Trial ... - Eagle-Tribune
Fractyl Health Advances Rejuva® Gene Therapy Platform with - GlobeNewswire
Breakthrough One-Time Gene Therapy Could Replace Daily Diabetes Drugs, Heads to European Trials - Stock Titan
China On the March as U.S. Investors Plough Back in After Tariff Tension - The Globe and Mail
Fractyl Health Unveils New Rejuva® Smart GLP-1™ Pancreatic Gene Therapy Preclinical Data Highlighting Durable Potency and Safety with Limited Systemic GLP-1 Exposure at ASGCT 2025 - The Manila Times
Fractyl Health Announces Promising Preclinical Data for RJVA-001, a Novel Gene Therapy for Type 2 Diabetes at ASGCT 2025 - Nasdaq
Fractyl Health Unveils New Rejuva® Smart GLP-1™ Pancreatic Gene Therapy Preclinical Data ... - Eagle-Tribune
Fractyl Health Unveils New Rejuva® Smart GLP-1™ Pancreatic - GlobeNewswire
Revolutionary One-Time GLP-1 Gene Therapy Achieves Powerful Diabetes Control with 5X Lower Side Effect Risk - Stock Titan
Prediction: Taiwan Semiconductor Stock Could Surge by 129% in the Next 5 Years - The Globe and Mail
CRSPR Stock Could Be Ready to Deliver on Its Massive Promise - The Globe and Mail
Analysts and Institutions Continue to Bet Big on Alphabet - The Globe and Mail
16,400 Shares in Fractyl Health, Inc. (NASDAQ:GUTS) Bought by Raymond James Financial Inc. - Defense World
Fractyl signals accelerated enrollment for REMAIN-1 study while advancing Rejuva clinical milestones - MSN
Forge Biologics Inks AAV Development and cGMP Manufacturing Deal with Fractyl Health - Genetic Engineering and Biotechnology News
Fractyl Health Partners with Forge for Rejuva Gene Therapy Development - Contract Pharma
Forge Biologics Announces AAV Development and cGMP Manufacturing Relationship with Fractyl Health to Advance Their Gene Therapy Platform for Patients with Metabolic Diseases - Business Wire
1 Super Stock Down 76% You'll Regret Not Buying on the Dip in 2025 - The Globe and Mail
Fractyl Health Announces First Quarter 2025 Financial Results and Business Updates - GlobeNewswire
Fractyl Health Q1 2025 Earnings Call Transcript - MarketBeat
Earnings call transcript: Fractyl Health’s Q1 2025 shows rising R&D costs - Investing.com Nigeria
FRACTYL HEALTH, INC. SEC 10-Q Report - TradingView
Should You Buy Roku Stock Now With $500 and Hold for 10 Years? - The Globe and Mail
These High-Growth Stocks Were Down Over 50% This Year. Is It Time to Buy Them? - The Globe and Mail
Fractyl Health (GUTS) Expected to Announce Earnings on Tuesday - Defense World
Fractyl Health to Report First Quarter 2025 Financial Results and Provide Business Updates on May 13, 2025, and Will Participate in an Upcoming Investor Conference - The Manila Times
Fractyl Health to Report First Quarter 2025 Financial - GlobeNewswire
Fractyl Health Sets Date for Q1 Earnings, Showcases Diabetes Therapeutics at Major Healthcare Conference - Stock Titan
Geode Capital Management LLC Purchases 11,603 Shares of Fractyl Health, Inc. (NASDAQ:GUTS) - Defense World
Fractyl Health, Inc. to Present Preclinical Data on Rejuva Gene Therapy Platform at ASGCT 2025 Annual Meeting - Nasdaq
Fractyl Health to Present Compelling Preclinical Data from its Rejuva® Single-Administration Smart GLP-1 Pancreatic Gene Therapy Platform at the American Society of Gene and Cell Therapy (ASGCT) 2025 Annual Meeting - The Manila Times
Fractyl Health to Present Compelling Preclinical Data from - GlobeNewswire
Discover Fractyl Health And 2 More Promising Penny Stocks - Yahoo Finance
Fractyl Health (NASDAQ:GUTS) Earns Buy Rating from Analysts at Canaccord Genuity Group - Defense World
These Were the 2 Worst-Performing Stocks in the S&P 500 in March 2025 - The Globe and Mail
Fractyl Health initiated with a Buy at Canaccord - TipRanks
Meta Stock Holds Its Head Up High amid Full-Blown Legal Migraine - The Globe and Mail
Raymond James Financial Inc. Makes New Investment in Fractyl Health, Inc. (NASDAQ:GUTS) - Defense World
Sei Investments Co. Acquires Shares of 27,778 Fractyl Health, Inc. (NASDAQ:GUTS) - Defense World
Norges Bank Makes New Investment in Fractyl Health, Inc. (NASDAQ:GUTS) - Defense World
Fractyl Health Inc (GUTS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.00%
0.54%
자본화:
|
볼륨(24시간):